Stocktoria
Aclaris Therapeutics, Inc. ACRS
Aclaris Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| CITADEL ADVISORS LLC | 2,818,019 | $10.6M | 2.3% |
| D. E. Shaw & Co., Inc. | 900,804 | $3.4M | 0.73% |
| MILLENNIUM MANAGEMENT LLC | 756,127 | $2.8M | 0.62% |
| BlackRock Finance, Inc. | 2,032,155 | $2.2M | 1.66% |
| RENAISSANCE TECHNOLOGIES LLC | 502,631 | $1.9M | 0.41% |
| TWO SIGMA INVESTMENTS, LP | 395,637 | $1.5M | 0.32% |
| AQR CAPITAL MANAGEMENT LLC | 72,408 | $271,530 | 0.06% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.